| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8672180 | Journal of Vascular Surgery | 2017 | 7 Pages |
Abstract
FEVAR is associated with a lower risk for 30-day mortality and adverse events compared with OS for AAA-Vs.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Prateek K. MD, Reshma MD, Kelly MD, Shaun M. MD, Michael J. MD,